UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy

Clinical journal of the American Society of Nephrology, 2019-08, Vol.14 (8), p.1173-1182

2019

Link zum Volltext

Verfügbarkeit prüfen

Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis

Neurotherapeutics, 2021-04, Vol.18 (2), p.938-948

2021

Link zum Volltext

Verfügbarkeit prüfen

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients

Frontiers in immunology, 2022-09, Vol.13, p.953502-953502

2022

Link zum Volltext

Verfügbarkeit prüfen

Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study

Frontiers in immunology, 2023-03, Vol.14, p.1136723-1136723

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review

Virology journal, 2012-08, Vol.9 (1), p.174-174, Article 174

2012

Link zum Volltext

Verfügbarkeit prüfen

Interactions between CD47 and Thrombospondin Reduce Inflammation

Journal of Immunology, 2007-05, Vol.178 (9), p.5930-5939

2007

Link zum Volltext

Verfügbarkeit prüfen

Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (7), p.2748-2756

2009

Link zum Volltext

Verfügbarkeit prüfen

Idiopathic CD4 T Cell Lymphocytopenia: A Case of Overexpression of PD-1/PDL-1 and CTLA-4

Infectious disease reports, 2021-01, Vol.13 (1), p.72-81

2021

Link zum Volltext

Verfügbarkeit prüfen

Switching to a Dual-Drug Regimen in HIV-Infected Patients Could Be Associated With Macrophage Activation?

Frontiers in medicine, 2021-08, Vol.8, p.712880-712880

2021

Link zum Volltext

Verfügbarkeit prüfen

The early phase of human sepsis is characterized by a combination of apoptosis and proliferation of T cells

Journal of critical care, 2012-08, Vol.27 (4), p.384-393

2012

Link zum Volltext

Verfügbarkeit prüfen

Cell-penetrating TAT-FOXO3 fusion proteins induce apoptotic cell death in leukemic cells

Molecular cancer therapeutics, 2011-01, Vol.10 (1), p.37-46

2011

Link zum Volltext

Verfügbarkeit prüfen

HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)

Heliyon, 2017-02, Vol.3 (2), p.e00245, Article e00245

2017

Link zum Volltext

Verfügbarkeit prüfen

CD47 and the 19 kDa Interacting Protein-3 (BNIP3) in T Cell Apoptosis

The Journal of biological chemistry, 2003-06, Vol.278 (26), p.23915-23921

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata

JAMA dermatology (Chicago, Ill.), 2014-07, Vol.150 (7), p.748

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2012-11, Vol.143 (5), p.1207-1217.e2

2012

Link zum Volltext

Verfügbarkeit prüfen

Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow

Blood, 2003-06, Vol.101 (12), p.4836-4843

2003

Link zum Volltext

Verfügbarkeit prüfen

Erratum to ‘HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)’

Heliyon, 2017-03, Vol.3 (3), p.e00259-e00259, Article e00259

2017

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations

Journal of investigative dermatology, 2021-04, Vol.141 (4), p.933-936.e6

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis

Journal of neuroimmunology, 2016-09, Vol.298, p.79-81

2016

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations

Journal of investigative dermatology, 2021, Vol.141 (4), p.933-936.e6

2021

Link zum Volltext

Verfügbarkeit prüfen

Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?

AIDS (London), 2014-02, Vol.28 (4), p.493-501

2014

Link zum Volltext

Verfügbarkeit prüfen

In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent

Haematologica (Roma), 2015-02, Vol.100 (2), p.223-230

2015

Link zum Volltext

Verfügbarkeit prüfen

Acceptable “Real‐Life” Variability for Lymphocyte Counts by Flow Cytometry

Cytometry. Part B, Clinical cytometry, 2019-09, Vol.96 (5), p.379-388

2019

Link zum Volltext

Verfügbarkeit prüfen

A Fixed-Duration Immunochemotherapy Approach Combined with Ibrutinib in CLL Produces Deep and Sustained MRD Responses: 5.5-Year Results from the Icll-07 Filo Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.7013-7015

2022

Link zum Volltext

Verfügbarkeit prüfen

Determination of acceptable limits of precision parameters for lymphocyte count by flow cytometry

Annales de biologie clinique (Paris), 2018-12, Vol.76 (6), p.687-693

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(90)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy

Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients

Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study

The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review

Interactions between CD47 and Thrombospondin Reduce Inflammation

Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest

Idiopathic CD4 T Cell Lymphocytopenia: A Case of Overexpression of PD-1/PDL-1 and CTLA-4

Switching to a Dual-Drug Regimen in HIV-Infected Patients Could Be Associated With Macrophage Activation?

The early phase of human sepsis is characterized by a combination of apoptosis and proliferation of T cells

Cell-penetrating TAT-FOXO3 fusion proteins induce apoptotic cell death in leukemic cells

HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)

CD47 and the 19 kDa Interacting Protein-3 (BNIP3) in T Cell Apoptosis

Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata

Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease

Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow

Erratum to ‘HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)’

Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations

Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis

Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations

Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?

In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent

Acceptable “Real‐Life” Variability for Lymphocyte Counts by Flow Cytometry

A Fixed-Duration Immunochemotherapy Approach Combined with Ibrutinib in CLL Produces Deep and Sustained MRD Responses: 5.5-Year Results from the Icll-07 Filo Trial

Determination of acceptable limits of precision parameters for lymphocyte count by flow cytometry

Suchergebnisse filtern